Avicanna Subsidiary Achieves First Commercial Export of CBG Cultivar to Australia
Minor cannabinoids clinical research is advancing with Avicanna's subsidiary completing the first commercial export of a CBG-dominant cultivar to Australia. CBG offers distinct therapeutic potential compared to THC and CBD. This milestone marks growing…
Effect of Cannabigerol on Sleep and Quality of Life in Veterans: A Decentralized, Randomized, Placebo-Controlled Trial
This cannabigerol sleep study veterans trial evaluated oral CBG for sleep quality in veterans with sleep disturbances. The study found a favorable safety profile but inconclusive efficacy results. It highlights the need for further research on CBG's…
CBD And CBG From Cannabis May Help Treat Liver Condition
CBD CBG preclinical research NAFLD highlights promising cannabis compounds for fatty liver disease. These compounds may reduce liver inflammation and steatosis. This research could advance treatment options for NAFLD patients.
Pharmacokinetic and Pharmacodynamic Properties of Cannabigerol in Male Mice
This study investigates the pharmacokinetic properties of cannabigerol in male mice, highlighting its brain penetration and metabolite accumulation. Findings reveal unexpected anxiogenic effects at peak brain concentrations. Understanding these…
In the Mix: 7 More Articles — March 16, 2026
This article mix highlights cannabis commercialization challenges impacting clinical cannabinoid therapeutics. It reviews product diversification and enforcement issues clinicians should know. Understanding these challenges aids informed patient…
CED Digest: 436 Items — March 14, 2026
This CED Digest highlights cannabis compounds fatty liver disease research with 436 clinically relevant items. CBD and CBG show promise in reducing hepatic steatosis and improving metabolic markers. Clinicians gain evidence-based insights into…
Cannabis Compounds CBD and CBG Show Promise in Fighting Fatty Liver Disease
Emerging cbd and cbg fatty liver research suggests these compounds may help modulate lipid accumulation and inflammation. This research offers hope for new therapeutic options in fatty liver disease. However, clinical trials are needed before…
CBD and CBG: Promising Treatments for Fatty Liver Disease
A new CBD and CBG fatty liver disease study highlights promising therapeutic potential for metabolic liver conditions. These cannabinoids may reduce liver fat and improve metabolic health. This study offers hope for new treatment options beyond lifestyle…
New Research on CBD and CBG for Fatty Liver Disease
Emerging research on cbd and cbg fatty liver disease shows potential therapeutic benefits beyond lifestyle modification. These non-intoxicating cannabis compounds may reduce liver fat and improve hepatic health. While promising, clinical trials are…
Daily Digest March 8, 2026: Cannabis News Highlights
This daily cannabis news digest provides top updates from the cannabis industry and research pipeline. Stay informed on medical cannabis news and policy developments. Our digest covers key highlights from March 8, 2026.